medigraphic.com
ISSN 2992-8559 (Electronic)
ISSN 1405-0625 (Print)

2019, Number 1

<< Back Next >>

Cir Plast 2019; 29 (1)

Seroma, an alert of pathologies related to breast implants. Evidence based medicine

Cuenca-Pardo J, Vélez BE, Ramos-Gallardo G, Iribarren MR

Language: Spanish
References: 50
Page: 15-34
PDF size: 346.08 Kb.


ABSTRACT

There is an under recording of the incidence of seroma related to breast implants. There is no uniform criterion regarding the treatment and the amount of fluid accumulated, to consider it as a pathological manifestation; to answer the questions of a scenario that frequently presents itself to a plastic surgeon, such as a woman with breast implants of several years of evolution has increased volume in one breast accompanied by swelling (we performed a systematic review). All patients with breast implants should have an annual medical check-up by their surgeon. When there is an increase in volume, asymmetries, and inflammation, the presence of a seroma should be ruled out. To check this an ultrasound and / or an MRI is required. In the case a seroma is confirmed, a puncture-aspiration of the liquid should be performed and sent to a laboratory study for cytochemical analysis, cultures, pathology studies, immunomarkers and flow cytometry. There are several breast pathologies that can be detected by the study of the aspirated fluid; the most dreaded is BIA-ALCL lymphoma. Most seromas resolve satisfactorily with conservative treatment. In a group of patients, seroma is an alert sign of different pathologies related to breast implants. The study of the fluid accumulated around the prostheses is very useful to determine the etiology of seromas.


REFERENCES

  1. Lista F, Ahmad J. Evidence-based medicine: augmentation mammaplasty. Plast Reconstr Surg 2013; 132 (6): 1684-1696.

  2. Ronchi A, Montella M, Argenzio V, Lucia A, De Renzo A, Alfano R et al. Diagnosis of anaplastic large cell lymphoma on late peri-implant breast seroma: management of cytological sample by an integrated approach. Cytopathology 2018; 29 (3): 294-299.

  3. Derby BM, Codner MA. Textured silicone breast implant use in primary augmentation: Core Data Update and Review. Plast Reconstr Surg 2015; 135: 113-124.

  4. Lista F, Tutino R, Khan A, Ahmad J. Subglandular breast augmentation with textured, anatomic, cohesive silicone implants: a review of 440 consecutive patients. Plast Reconstr Surg 2013; 132 (2): 295-302.

  5. Bengtson B, Brody GS, Brown MH, Glicksman C, Hammond D, Kaplan H et al. Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature. Plast Reconstr Surg 2011; 128 (1): 1-7.

  6. Jordan SW, Khavanin N, Kim JYS. Seroma in prosthetic breast reconstruction. Plast Reconstr Surg 2016; 137 (4): 1104-1116.

  7. Brohim RM, Foresman PA, Hildebrandt PK, Rodeheaver GT. Early tissue reactions to textured breast implant surfaces. Ann Plast Surg 1992; 28: 354-362.

  8. Malata CM, Feldberg L, Coleman DJ, Foo IT, Sharpe DT. Textured or smooth implants for breast augmentation? Three year follow-up of a prospective randomized controlled trial. Br J Plast Surg 1997; 50: 99-105.

  9. Coleman DJ, Foo IT, Sharpe DT. Textured or smooth implants for breast augmentation? A prospective controlled trial. Br J Plast Surg 1991; 44: 444-448.

  10. Collis N, Coleman D, Foo IT, Sharpe DT. Ten-year review of a prospective randomized controlled trial of textured versus smooth subglandular silicone gel breast implants. Plast Reconstr Surg 2000; 106: 786-791.

  11. Hall-Findlay EJ. Breast implant complication review: Double capsules and late seromas. Plast Reconstr Surg 2011; 127: 56-66.

  12. Spear SL, Rottman SJ, Glicksman C, Brown M, Al-Attar A. Late seromas after breast implants: Theory and practice. Plast Reconstr Surg 2012; 130: 423-435.

  13. Santanelli di Pompeo F, Laporta R, Sorotos M, Di Napoli A, Giovagnoli MR et al. Breast implant–associated anaplastic large cell lymphoma: proposal for a monitoring protocol. Plast Reconstr Surg 2015; 136: 144e-151e.

  14. Di Napoli A. Achieving reliable diagnosis in late breast implant seromas: from reactive to anaplastic large cell lymphoma. Plast Reconstr Surg 2019; 143: 15S-22S.

  15. Becker H, Klimczak J. Aspiration of periprosthetic seromas using the blunt seroma cath. Plast Reconstr Surg 2016; 137 (2): 473-475.

  16. Chourmouzi D, Vryzas T, Drevelegas A. New spontaneous breast seroma 5 years after augmentation: A case report. Cases J 2009; 2: 7126.

  17. Fodor L, Moscona R. Late post-traumatic intracapsular seroma after breast augmentation. J Plast Reconstr Aesthet Surg 2009; 62: e609-e610.

  18. Hasham S, Akhtar S, Fourie LR. Persistent seroma following breast prosthesis explantation: A case report and review. Eur J Plast Surg 2006; 28: 490-493.

  19. Mazzocchi M, Dessy LA, Carlesimo B, Marchetti F, Scuderi N. Late seroma formation after breast surgery with textured silicone implants: a problem worth bearing in mind. Plast Reconstr Surg 2010; 125: 176e-177e.

  20. Mazzocchi M, Dessy LA, Corrias F, Scuderi N. A clinical study of late seroma in breast implantation surgery. Aesthet Plast Surg 2012; 36 (1): 97-104.

  21. Oliveira VM, Roveda-Junior D, Lucas FB et al. Late seroma after breast augmentation with silicone prostheses: a case report. Breast J 2007; 13: 421-423.

  22. Tansley PD, Powell BW. Late swelling after bilateral breast augmentation. J Plast Reconstr Aesthet Surg 2011; 64: 261-263.

  23. Pinchuk V, Tymofii O. Seroma as a late complication after breast augmentation. Aesthet Plast Surg 2011; 35 (3): 315-318.

  24. Bumaschny E, Raffa CI, Reichman P. Evaluación preoperatoria del paciente quirúrgico. En: F Galindo et al. Enciclopedia de cirugía digestiva. Buenos Aires: 2013; tomo I -101, pp. 1-20. www.sacd.org.ar

  25. Guía de Referencia Rápida. Diagnóstico y tratamiento de la infección aguda, no complicada del tracto urinario en la mujer. Guía de Práctica Clínica IMSS-077-08.

  26. López-Tagle D, Hernández-Ferrer M, Saldivar-Arias T, Sotolongo-Hernández T, Valdés-Dupeyrón O. Infección de la herida quirúrgica: aspectos epidemiológicos. Rev Cub Med Mil 2007; 36 (2): 1-11.

  27. Pineda V, Cáceres J, Pernas JC, Català J. Retromammary fluid collection as a late complication of breast implants: magnetic resonance imaging findings. J Comput Assist Tomogr 2004; 28: 386-389.

  28. Bengtson BP, Eaves FF III. High-resolution ultrasound in the detection of silicone gel breast implant shell failure: background, in vitro studies, and early clinical results. Aesthet Surg J 2012; 32: 157-174.

  29. Chung KC, Malay S, Shauver MJ, Kim HM. Economic analysis of screening strategies for rupture of silicone gel breast implants. Plast Reconstr Surg 2012; 130: 225-237.

  30. McCarthy CM, Pusic AL, Kerrigan CL. Silicone breast implants and magnetic resonance imaging screening for rupture: do U.S. Food and Drug Administration recommendations reflect an evidence-based practice approach to patient care. Plast Reconstr Surg 2008; 121 (4): 1127-1134.

  31. Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J 2019; 39: S3-S13.

  32. Adams WP, Bengston BP, Glicksman CA et al. Decision and management algorithms to address patient and food and drug administration concerns regarding breast augmentation and implants. Plast Reconstr Surg 2004; 114: 1252-1257.

  33. Gray L. Silicone breast implants and magnetic resonance imaging screening for rupture: Do U.S. Food and Drug Administration recommendations reflect an evidence based practice approach to patient care? Plast Reconstr Surg 2008; 122: 1591-1592.

  34. Song JW, Kim HM, Bellfi LT, Chung KC. The effect of study design biases on the diagnostic accuracy of magnetic resonance imaging for detecting silicone breast implant ruptures: A meta-analysis. Plast Reconstr Surg 2011; 127: 1029-1044.

  35. Handel N, Garcia ME, Wixtrom R. Breast implant rupture: causes, incidence, clinical impact, and management. Plast Reconstr Surg 2013; 132: 1128-1137.

  36. Gunawardana RT, Dessauvagie BF, Taylor DB. Breast implant-associated anaplastic large cell lymphoma, an under-recognized entity. J Med Imaging Radiat Oncol 2019. https://doi.org/10.1111/1754-9485.12905.

  37. Leberfinger AN, Behar BJ, Williams NC, Rakszawski KL, Potochny JD, Mackay DR, Ravnic DJ. Breast implant-associated anaplastic large cell lymphoma: a systematic review. JAMA Surg 2017; 152 (12): 1161-1168.

  38. Fitzal F, Turne SD, Kenner L. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery? Open Biol 2019; 9: 190006. https://doi.org/10.1098/rsob.190006

  39. Mazzocchi M, Dessy LA, Marchetti F, Marchetti F, Carlesimo B. The use of the Veress needle to drain mammary periprosthetic fluid. In Vivo 2010; 24: 219-222.

  40. Garcia-Tutor E, Murillo J. Safe drainage by puncture of post mastectomy seroma in a patient with immediate reconstruction using an expander. Plast Reconstr Surg 2003; 111: 1357-1358.

  41. Moyer KE, Potochny JD. Technique for seroma drainage in implant-based breast reconstruction. J Plast Reconstr Aesthet Surg 2012; 65: 1614-1617.

  42. Ramos-Gallardo G, Cuenca-Pardo J, Rodríguez-Olivares E, Iribarren-Moreno R, Contreras-Bulnes L, Vallarta-Rodríguez A et al. Breast implant and anaplastic large cell lymphoma meta-analysis. J Invest Surg 2017; 30: 56-65.

  43. Pinsolle V, Grinfeder C, Mathoulin-Pelissier S, Faucher A. Complications analysis of 266 immediate breast reconstructions. J Plast Reconstr Aesthet Surg 2006; 59: 1017-1024.

  44. Francis SH, Ruberg RL, Stevenson KB, Beck CE, Ruppert AS, Harper JT et al. Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg 2009; 124: 1790-1796.

  45. Nahabedian MY, Tsangaris T, Momen B, Manson P. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 2003; 112: 467-476.

  46. Rubino C, Brongo S, Pagliara D, Cuomo R, Abbinante G et al. Infections in breast implant: a review a focus and developing countries. J Infect Dev Ctries 2014; 8 (9): 1089-1095.

  47. Washer LL, Gutowski K. Breast implant infections. Infect Dis Clin N Am 2012; 26: 111-125.

  48. Cuenca-Pardo J, Ramos-Gallardo G, Contreras-Bulnes L, Iribarren-Moreno R, Rodríguez-Olivares E, Hernández-Valverde C et al. Factores relacionados con infecciones en implantes mamarios. Cir Plast 2015; 25 (1): 6-14.

  49. Barrera-Ramírez L, Drago-Serrano ME, Pérez-Ramos J, Zamora AC, Gómez-Arroyo F, Sainz-Espuñes T et al. Citometría de flujo: vínculo entre la investigación básica y la aplicación clínica. Rev Inst Nal Enf Resp Mex 2004; 17 (1): 42-55.

  50. Lopresti A, Malergue F, Bertucci F, Liberatoscioli ML, Garnier S, DaCosta Q et al. Sensitive and easy screening for circulating tumor cells by flow cytometry. JCI Insight 2019; 5. pii: 128180. doi: 10.1172 / jci.insight.128180.




2020     |     www.medigraphic.com